Search
ADC Therapeutics SA
ADCTAdd to Watchlist
1.070USD
-0.040-3.60%
Close 09-11 16:00（ET）
135.08MMarket Cap
LossP/E TTM
After-hours 19:00 (ET)1.070USD+0.005+0.47%
After-hours 19:00 (ET)TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-3.60%
5 Days
-21.32%
1 Month
-9.32%
6 Months
-78.07%
Year to Date
-69.69%
1 Year
-67.87%
Key Figures
1.130Open
1.156High
252.90KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.20%Turnover Ratio
1.110Prev. Close
1.040Low
270.08KTurnover
LossP/E Static
-0.59P/B
0.00%Div Yield TTM
-48.57%ROA
4.98052wk High
62.82Volume Ratio
-157.85MNet Profit
127.44MShares
-0.9762EPS TTM
1.79Beta
-199.54%ROE
0.78052wk Low
9.91%Amplitude
89.23%Gross Margin
135.08MMarket Cap
-4.68Reward/Risk
5.88%Risk Rate
ADC Therapeutics SA's Score
-0.27vs previous score
Forecast7.00
Financial Health7.65
Technical4.95
Valuation Dimensions8.38
Institutional Confidence5.00
Risk Assessment2.30
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
ADC Therapeutics SA Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
ADC Therapeutics SA Latest Earnings Call Transcripts
ADC Therapeutics (ADCT) Q2 2026 Earnings Call: LOTIS-5 FDA Concerns, $219.1M Cash
ADC Therapeutics Q2 2026 earnings call: ZYNLONTA revenue reached $18.6 million, while FDA concerns clouded the LOTIS-5 regulatory path.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.11/-0.21
Revenue / Forecast
19.25M/19.38M
ADC Therapeutics SA Profile
SectorBiotechnology & Medical Research
Ticker SymbolADCT
Number of employees263
CountrySwitzerland
Ownership
| Shareholders | Proportion |
|---|---|
| Redmile Group, LLC | 9.91% |
| TCG Crossover Management, LLC | 8.96% |
| HPWH TH AG | 6.82% |
| Prosight Capital | 6.67% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor/Hedge Fund | 21.16% |
| Investment Advisor | 18.99% |
| Hedge Fund | 15.93% |
| Corporation | 6.82% |
Related Instruments
-0.65%
-0.29%
+0.33%
+0.83%
-0.54%
-0.23%
-1.34%
-0.75%
+0.25%
-2.14%
+0.17%
-0.17%
+0.12%
+0.07%
+0.02%
-1.48%
+0.04%
+0.83%
+5.38%
-0.61%
FAQs
What is the current price of ADC Therapeutics SA (ADCT)?
The current price of ADC Therapeutics SA (ADCT) is 1.07.
What is the symbol of ADC Therapeutics SA?
The ticker symbol of ADC Therapeutics SA is ADCT.
What is the 52-week high of ADC Therapeutics SA?
The 52-week high of ADC Therapeutics SA is 4.98.
What is the 52-week low of ADC Therapeutics SA?
The 52-week low of ADC Therapeutics SA is 0.78.
What is the market capitalization of ADC Therapeutics SA?
The market capitalization of ADC Therapeutics SA is 135.08M.
Is ADC Therapeutics SA (ADCT) currently rated as Buy, Hold, or Sell?
According to analysts, ADC Therapeutics SA (ADCT) has an overall rating of Buy, with a price target of 2.62.
What is the Earnings Per Share (EPS TTM) of ADC Therapeutics SA (ADCT)?
The Earnings Per Share (EPS TTM) of ADC Therapeutics SA (ADCT) is -0.98.